Acute immune trobocytopenic purpura in pregnant adolescent

Česká verzia

Authors: T. Binder ¹; J. Biolek ²; A. Srbová ³; D. Procházková ⁴; A. Vašková ⁵; F. Fadi ¹; M. Pánek ⁶
Authors place of work: Gynekologicko-porodnická klinika UJEP a Masarykovy nemocnice, Ústí nad Labem, přednosta doc. MUDr. T. Binder, CSc. ¹; Dětské a dorostové oddělení nemocnice Most, primářka MUDr. M. Váchová ²; Ústav hematologie a krevní transfuze, Praha, ředitel prof. MUDr. P. Cetkovský, Ph. D., MBA ³; Dětská klinika UJEP a Masarykovy nemocnice, Ústí nad Labem, přednosta MUDr. J. Škvor, CSc. ⁴; Oddělení klinické hematologie Masarykovy nemocnice, Ústí nad Labem, primářka MUDr. J. Ullrychová ⁵; Neonatologická klinika UJEP a Masarykova nemocnice, Ústí nad Labem, přednosta MUDr. P. Hitka, Ph. D. ⁶
Published in the journal: Ceska Gynekol 2019; 84(6): 443-449
Category:

Summary

Objective: The article reviews the causes of thrombocytopenia in pregnancy and the basic examination scheme. Further, it deals in more details with diagnosis of immune thromocytopenic purpura (ITP) and presents a case report of a rare case of acute severe ITP in pregnant adolescent.

Design: Review article and case report.

Settings: Department Obstet/Gynecol Uni J. A. Purkyně and Masaryk´s Hospital, Ústí nad Labem; Children and adolescent dep. Hospital Most; Institute of Hematology and Blood Transfusion Prague; Department of Children Med. Uni J. A. Purkyně and Masaryk´s Hospital, Ústí nad Labem; Department of Clinic Hematology Masaryk´s Hospital, Ústí nad Labem; Department of Neonatology Uni J. A. Purkyně and Masaryk´s Hospital, Ústí nad Labem.

Methods: Based on a review of the published papers, general rules for diagnosis, treatment, fetal risks, pregnancy management and labor in women with immune thrombocytopenic purpura (ITP) are given. Further we present the case of a 16-year-old pregnant girl with an acute severe form of ITP not responding to corticosteroid treatment who underwent twice critical decline of platelets up to 1×10⁹ and repeatedly it was necessary to access the application of IVIG and Azathioprim (Imuran) was also used in her treatment. Pregnancy was unplanned terminated for dg. placental abortion in gestational age 32+4.The girl of 1740 g/42 cm was born with Apgar score 10–10–10 with no signs of thrombocytopenia. Surgery and postoperative course in the mother without complications. The newborn was discharged from the hospital into home care at a gestational age of 36+1 along with his mother.

Results: We present a case of acute severe form of ITP in pregnancy with a successful though somewhat dramatic end.

Conclusions: These rare cases are demanding in terms of logistical, personnel and material provision. The aim of the treatment is to achieve a satisfactory maturity of the fetus, the treatment is financially demanding and is not without risks. Therefore, these cases should only be dealt with at Perinatology Centers in close cooperation with hematologists and neonatologists.

Keywords:

pregnancy – immune trobocytopenic purpura

Zdroje

1. ACOG practice bulletin: thrombocytopenia in pregnancy. Number 6, Sept. 1999. Clinical management qudelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet, 1999, 67(2), p. 117–128.

2. Boehlen, F., Samii, K., Epieney, M. Management of thrombocytopenia during pregnancy. Rev Med Suisse, 2011, 9(281), p. 340–344.

3. Cines, DB.,Levine, LD. Thrombocytopenia in pregnancy. Blood, 2017, 130(21), p. 2271–2277.

4. Federici, L., Serraj, K., Maloisel, F., Andrés, E. Thrombocytopenia during pregnancy: from etiologic diagnosis to therapeutic management. Presse Med, 2008, 37, p. 1299–1307.

5. Johnson, JR., Samuels, P. Review of autoimmune thromocytopenia: patogenesis, diagnosis and management in pregnacy.Clin Obstet Gynecol, 1999, 42(2), p. 317–326.

6. Magann, EF., Martin, JN. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol, 1999, 42, p. 532.

7. No authors listed Practice Bulletin No.166: Thrombocytopenia in pregnancy. Obstet Gynecol, 2016, 128(3), p. 43–53.

8. Perepu, U., Rosenstein, L. Maternal thrombocytopenia in pregnancy. Obstet Gynecol, 2013, 3(1):Article 6.

9. Rehberg, JF, Briery, CM., Hudon, WT., et al.Thrombotic thrombopenic purpura masquerading as hemolysis, elevated liver enzymes, low plateles (HELLP) syndrome in late pregnancy. Obstet Gynecol, 2006, 108, p. 817–820.

10. Silver, RM. Management of idiopathic thromocytopenic purpura in pregnancy. Clin Obstet Gynecol, 1998, 41(2), p. 436–448.

11. Stavrou, E., McCrae, KR. Immune thrombocytopenia in pregnancy. Hematol Oncol Clin North Am, 2009, 23(6), p. 1299–1316.

12. Šimetka, O., Klát, J., Gumulec, J., et al. Early identification of women with HELLP syndrome who need plasma exchange after delivery. Transf apheresis Sc, 2015, 2(1), p. 54–59.

13. Uhrynowska, M., Niznikowska-Marks, M., Zupanska, B. Neonatal and maternal thrombocytopenia: incidence and immune background. Eur J Hematol, 2000, 64(1), p. 42–46.

14. Yan, M., Malinowski, AK., Shehata, N. Thrombocytopenic syndroms in pregnancy. Obstet Med, 2016, 9(1), p. 15–20.